Commercial Systems Architecture for Pharma & Life Sciences.
New Title
Together, We Will Build the Commercial System Your Science Deserves.
Prescribing intent is earned through extraordinary scientific investment, clinical rigor, and field execution. But intent is not impact. The script is not the finish line. In too many therapeutic areas, the value that has been commercially earned is systematically left unrealized, not because the science fails, but because the system surrounding it was never designed to ensure it reaches patients.
40%
or more of written scripts go unfilled in some therapeutic areas
30%
of patients discontinue within the first 90 days
31%
of Rx decisions influenced by experience, not brand and product alone
WINNERS BELIEVE IN THE FIELD.
The Field Is Still Where Commercial Advantage Will Be Won or Lost.
FEATURED advisory offering
The Operating System for
Pharma’s Realization Unlock.
Most field organizations optimize activity, yet what happens to clinical intent after the interaction and script decision is often managed reactively. FieldOS™ is a purpose-built reference architecture that embeds Journey Operations into field enablement, equipping organizations to systematically remove barriers so clinical belief converts into sustained clinical and commercial impact.
Redefine What Field Effectiveness Success, Measurement and Governance Means.
Shift field effectiveness from counting calls to governing journeys, embedding accountability for progression across prescribing, fulfillment, and adherence to protect intent and drive sustained impact.
Align the Commercial System Around Journey Progression, Not Functional Silos.
Move from cross-functional fragmentation to a shared architecture of progression and continuity, aligning field, marketing, access, and patient support around the barriers that break clinical intent before it becomes patient impact.
Build Field Workflows to Systematically Identify and Eliminate Journey Barriers.
Convert AI-powered frontline insights into structured learning loops to preemptively identify journey barriers, reduce Customer Value at Risk, and strengthen therapy initiation and persistence.
Build the Operational Cadence and Accountability That Makes Impact Self-Sustaining.
Tailor the reference architecture and workflows to drive field effectiveness by hardwiring accountability into leadership cadence, incentive design, and cross-functional execution, so impact compounds rather than reverts.
SUPPORTING advisory offering
Elevate Experience from Stall to Scale by Integrating It Organically Into the Commercial Engine.
Pharma CX has stalled. Models imported from other industries sit adjacent to sales and marketing instead of embedded within the commercial engine. Surveys generate data without action, sentiment is tracked without shifting behavior, and value realization remains illusive. CX 3.0 — Fit for Pharma Reboot is an industry-specific, AI-powered approach to integrate CX into the commercial operating model, aligning leadership, incentives, and workflows to drive sustained patient and commercial impact.
SUPPORTING ADVISORY OFFERING
Bring discipline and truth to how your brand shows up, aligning brand promise with lived experience.
Every interaction is now brand-defining. Most organizations build Brand Design Systems that define identity and voice standards. Few build the system that governs brand behavior, resulting in drift between promise and lived experience. The Brand Experience Activation and Turnaround Sprint is a focused co-design methodology that builds and deploys the Brand Experience Delivery System, the counterpart to the design system, translating experiential brand principles into governed interaction standards across journeys and channels so every touchpoint consistently reinforces the brand.
A Track Record Proven at Enterprise and Global Scale.
FEATURED DOWNLOAD.
Decode Pharma's New Commercial Reality.
Get Your Purpose-Built Commercial Strategy Playbook.
Pharma’s commercial model is being reset by a fundamentally changed HCP customer context and rising consumer-grade expectations. Experience now determines whether prescribing intent progresses to real-world care, whether written scripts translate into treatment, and whether value is ultimately realized or lost. This playbook decodes where value leaks, why conventional approaches fail to address it, and the system-level choices leaders must make to ensure their breakthrough science is matched by experiences worthy of it.
Get Started Today.
Get the Playbook.
